tecoimage tecoimage tecoimage tecoimage
tecoimage tecoimage
DE | FR | EN | PRINT
tecoimage tecoimage
tecoimage tecoimage tecoimage
tecoimage tecoimage tecoimage
tecoimage
tecoimage tecoimage tecoimage
tecoimage

Bone metabolism Product details

Productname BAP MicroVue™ Quidel®

Bone-specific Alkaline Phosphatase, Enzyme activity of bound BAP is measured

Cat-No. 8012
Range 2-140 U/l (1-70 µg/l)
Sensitivity 0.7 U/l
Incubation time 3.5 hours
Sample volume 20 µl
Sample type

Heparinized plasma, serum, cell culture

Sample preparation

Plasma samples should not be treated with EDTA or citrate because of the inhibition of the BAP enzyme. Keep samples refrigerated at 2-8°C for storage of less than 5 days. For long-term storage freeze specimens at -20°C or below.

Reference values
  U/L
Female (25 - 44 years Premenopausal) 11.6 - 29.6
Female (≥ 45 years Postmenopausal) 14.2 - 42.7
Male (> 25 years) 15.0 - 41.3

Reference values from children are available. 

Species

Human, rabbit, porcine, dog, cat, sheep, goat, bovine, horse, baboon, rhesus macaque, cynomolgus macaque

Cross reaction

Minimal cross-reactivity to liver (3 – 8%), intestinal (0.4%) and placental (0%) alkaline phosphatases.

Tests 96 Tests
Method ELISA
Product informations - Literature: BAP Monograph (pdf-File 1,118 kb)
- Kit Instructions (pdf-File 193 kb)
- Animal reference Values (pdf-File 25 kb)
- Children reference Values (pdf-File 400 kb)
- Cross-reaction all species (pdf-File 71 kb)
- Cell culture (pdf-File 93 kb)
- Datasheet (pdf-File 131 kb)
- Bone & Cartilage Metabolism (pdf-File 2,480 kb)
- Information: Laboratory Parameters Nephrology and Dialysis (pdf-File 199 kb)
Intended use

BAP (bone specific alkaline phosphatase) is a highly specific marker of osteoblast activity during bone remodeling. Measurement of BAP is intended for use as an aid in:

  • management of postmenopausal osteoporosis and Paget’s disease.
  • monitoring postmenopausal women on hormonal or bisphosphonate therapy.
  • predicting skeletal response to hormonal therapy in postmenopausal women.
  • diagnostic analysis metastasis.

See also reference: Clinical & Technical Monograph: Bone specific alkaline phosphatase (BAP).

Keywords product

BAP, ELISA, Bone-specific alkaline phosphatase, Bone remodeling, Bone formation Paget's disease, Bone turnover, Postmenopausal osteoporosis, Therapy efficiency, Bone metastasis, Bone marker, Osteoporosis therapy prim./sec., Hyperparathyroidism

Medical Devices, Angiogenese, Tierassays, Spezielle Parameter, Knochenstoffwechsel, Kalziumstoffwechsel, KnorpelstoffwechselBack to overview      print view
tecoimage tecoimage
tecoimage tecoimage tecoimage tecoimage
 
tecoimage tecoimage tecoimage tecoimage